Partners & Collaborators
If you have questions about research at Avera, call the Avera Research Institute at 605-322-3050.
Advancing Medical Research through Partnerships
Bringing experts together is the best way to learn and discover new treatments and therapies. Avera strongly believes in the power of collaboration and continues to develop relationships with experts throughout the region, across the nation and around the world.
By advancing science through numerous partnerships, Avera can translate this knowledge to improve the care provided to our patients and communities.
Avera McKennan Hospital & University Health Center has developed a formal working agreement for further collaboration with Vrije University (VU) in Amsterdam, The Netherlands. Through the agreement, the Avera Institute for Human Genetics is the genetics lab that performs not only all of the genotyping for the Netherlands Twin Register, but also the genotyping for future genetics research in partnership with VU, in addition to genotyping for the Avera Twin Register. Together, we work to advance research in genetics and genetic epidemiology.
Learn how the Avera team collaborates with Dr. Dorret Boomsma, an internationally-recognized leader in twins research, and her team at VU.
The Netherlands Twin Register (NTR) provides insight into how genetics and the environment influence individual differences by examining the contribution of hereditary predisposition to such characteristics as personality, development, disease and risk factors for disease.
Since it began in 1987, over 25,000 twins and multiples between ages 15 and 70 and over 62,000 twins between birth and age 15 have registered. Over 175,000 participants total are registered with the NTR including multiples and their family members such as parents, siblings and spouses.
View published papers from Avera's partnership with the Vrije University.
University of Nebraska Medical Center
Avera McKennan also partners with the University of Nebraska Medical Center Fred & Pamela Buffett Cancer Center to conduct cancer research. This collaboration brings cancer and genetics experts together to develop improved prevention and treatment strategies. Currently, a registry for breast cancer has been developed through this partnership.
MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leader in cancer care and research, designated by the National Cancer Institute as a Comprehensive Cancer Center. Through collaboration on a Grand Opportunity (GO) grant awarded by the National Institutes of Health, the Avera Institute for Human Genetics proudly continues its research relationship with Paul Scheet, PhD, an associate professor in The University of Texas MD Anderson Cancer Center's Department of Epidemiology and well-respected researcher in the areas of statistical genetics and cancer genomics.